Icon

About Amp⬩lif⬩AI

Icon

About Amp⬩lif⬩AI

Icon

About Amp⬩lif⬩AI

Image
Amplifai exists to close the gap between a working prototype and real-world adoption — across fragmented markets, payers and regulators.
Amplifai exists to close the gap between a working prototype and real-world adoption — across fragmented markets, payers and regulators.
“We turn APACMed’s convening power into a structured pathway that moves MedTech from promise to practice.”
Image

The Amplifai Team

Operated by NZmark, in partnership with APACMed

“We turn APACMed’s convening power into a structured pathway that moves MedTech from promise to practice.”
Image

The Amplifai Team

Operated by NZmark, in partnership with APACMed

Icon

How Amp⬩lif⬩AI works

Three pillars, one trajectory

Icon

How Amp⬩lif⬩AI works

Three pillars, one trajectory

Co-create

We bring innovators together with the industry leaders, health systems and regulators who shape adoption — built for the real world from day one.

Co-create

We bring innovators together with the industry leaders, health systems and regulators who shape adoption — built for the real world from day one.

Icon
Scale

We open doors to APAC markets, distribution partners and capital, with practical playbooks for cross-border growth.

Icon
Scale

We open doors to APAC markets, distribution partners and capital, with practical playbooks for cross-border growth.

Icon
Sustain

We focus on adoption that lasts: reimbursement, integration and partnerships that outlive a single launch.

Icon
Sustain

We focus on adoption that lasts: reimbursement, integration and partnerships that outlive a single launch.

Icon
The Forum moment

From 2027, cohort companies take the MedTech Forum stage and meet the people who can help them scale.

Icon
The Forum moment

From 2027, cohort companies take the MedTech Forum stage and meet the people who can help them scale.

Icon

Our commitment

To empower MedTech innovators with the partnerships, market access and hands-on support that drive sustainable, patient-centred growth across Asia-Pacific.

Icon

Our commitment

To empower MedTech innovators with the partnerships, market access and hands-on support that drive sustainable, patient-centred growth across Asia-Pacific.

Partnership-driven

Warm doors into MNCs, providers, regulators and investors.

Market access

Playbooks and introductions for cross-border growth.

Hands-on support

Senior operators working alongside your team.

Patient-centred

Outcomes measured by the difference they make to care.

Partnership-driven

Warm doors into MNCs, providers, regulators and investors.

Market access

Playbooks and introductions for cross-border growth.

Hands-on support

Senior operators working alongside your team.

Patient-centred

Outcomes measured by the difference they make to care.

Partnership-driven

Warm doors into MNCs, providers, regulators and investors.

Market access

Playbooks and introductions for cross-border growth.

Hands-on support

Senior operators working alongside your team.

Patient-centred

Outcomes measured by the difference they make to care.

Icon

Our story

Icon

Our story

Great healthcare innovation rarely fails for lack of a good idea — it stalls in the gap between prototype and adoption. Amplifai exists to close that gap.
Great healthcare innovation rarely fails for lack of a good idea — it stalls in the gap between prototype and adoption. Amplifai exists to close that gap.

Over three years we convene startups, corporates, providers, investors and policymakers around one goal: turning MedTech innovation into measurable impact — showcased at the APACMed MedTech Forum from 2027.

Delivered with APACMed — the region’s unifying MedTech voice since 2014.

Plugged into the APACMed Innovation Community and its accelerator and investor network.

Structured diagnostics, matched solvers and scoped pilots.

Anchored in scoped pilots and measurable outcomes — showcased at the APACMed MedTech Forum.

Outcomes tracked and reported honestly.

Over three years we convene startups, corporates, providers, investors and policymakers around one goal: turning MedTech innovation into measurable impact — showcased at the APACMed MedTech Forum from 2027.

Delivered with APACMed — the region’s unifying MedTech voice since 2014.

Plugged into the APACMed Innovation Community and its accelerator and investor network.

Structured diagnostics, matched solvers and scoped pilots.

Anchored in scoped pilots and measurable outcomes — showcased at the APACMed MedTech Forum.

Outcomes tracked and reported honestly.

story Image
Story Image
Image
Icon

Our Vision

Innovation.

Integration. Impact.

Co-Creation Sprints pair leadership teams with shortlisted solvers, and every pilot is scoped with an owner, a budget and an evidence plan. Results are reported quarterly on the Outcomes Dashboard, and the strongest work goes to the MedTech Forum stage from 2027.

APACMed convenes the ecosystem

Icon

Amplifai turns convening into a structured pathway

Icon

Cohorts culminate on the Forum stage from 2027

Icon

Our Vision

Innovation.

Integration. Impact.

Co-Creation Sprints pair leadership teams with shortlisted solvers, and every pilot is scoped with an owner, a budget and an evidence plan. Results are reported quarterly on the Outcomes Dashboard, and the strongest work goes to the MedTech Forum stage from 2027.

APACMed convenes the ecosystem

Icon

Amplifai turns convening into a structured pathway

Icon

Cohorts culminate on the Forum stage from 2027

Icon

FAQs

Got Questions?

We’ve Got Answers

Icon

FAQs

Got Questions?

We’ve Got Answers

Faq Image
Faq Image
What is Amp⬩lif⬩AI?

Amplifai is NZmark’s three-year innovation program, delivered with APACMed, that helps MedTech startups, partners and sponsors move from promise to practice across Asia-Pacific.

How is Amp⬩lif⬩AI related to APACMed and the MedTech Forum?

Amplifai is operated by NZmark in collaboration with APACMed. Cohort results are showcased at the APACMed MedTech Forum from 2027.

Who is Amp⬩lif⬩AI for?

Three audiences: innovators (MedTech startups joining the cohort), partners (APACMed members, MNCs, accelerators and investors), and sponsors (companies reaching the ecosystem).

When is the Amplifai showcase?

At the MedTech Forum from 2027 — dates and venue to be confirmed.

How do I get involved?

Tell us who you are via the contact form and we’ll point you to the right next step — applying to the cohort, partnering, or sponsoring.

What is Amp⬩lif⬩AI?

Amplifai is NZmark’s three-year innovation program, delivered with APACMed, that helps MedTech startups, partners and sponsors move from promise to practice across Asia-Pacific.

How is Amp⬩lif⬩AI related to APACMed and the MedTech Forum?

Amplifai is operated by NZmark in collaboration with APACMed. Cohort results are showcased at the APACMed MedTech Forum from 2027.

Who is Amp⬩lif⬩AI for?

Three audiences: innovators (MedTech startups joining the cohort), partners (APACMed members, MNCs, accelerators and investors), and sponsors (companies reaching the ecosystem).

When is the Amplifai showcase?

At the MedTech Forum from 2027 — dates and venue to be confirmed.

How do I get involved?

Tell us who you are via the contact form and we’ll point you to the right next step — applying to the cohort, partnering, or sponsoring.